Get reimbursed for COVID-19 testing and treatment of uninsured individuals.     Learn more »

Sickle Cell Disease Treatment Demonstration Program

Technical Assistance Webinar

Sickle Cell Demonstration TA Webinar HRSA Exit Disclaimer

Announcement Number:
HRSA-21-032

Bureau/Office:
Maternal & Child Health Bureau

Date(s) to Apply:
02/23/2021 to 05/03/2021

Estimated Award Date:
09/01/2021


What is the program?

This notice announces the opportunity to apply for funding under the Sickle Cell Disease Treatment Demonstration Program (TDP). The purpose of the TDP is to increase access for individuals with sickle cell disease (SCD) to quality, coordinated, comprehensive care by: 1) increasing the number of clinicians or health professionals knowledgeable about the care of SCD, 2) improving the quality of care provided to individuals with SCD, and 3) improving care coordination with other providers.


Are you eligible?

Eligible applicants include a Federally-qualified health center, a nonprofit hospital or clinic, or a university health center that provides primary health care, that has a collaborative agreement with a community-based sickle cell disease organization or a nonprofit entity with experience in working with individuals who have sickle cell disease; and demonstrates to the HRSA Administrator that either the federally-qualified health center, the nonprofit hospital or clinic, the university health center, the organization or entity described in clause (i) 42 USC § 300b-5, or experts as described in paragraph (2)(C) of 42 USC § 300b-5, has at least five (5) years of experience in working with individuals who have sickle cell disease. Federally-qualified health center is defined in section 1905(l)(2)(B) of the Social Security Act (42 U.S.C. 1396d(l)(2)(B)).

Apply

Contact Us

Alisha S. Keehn, MPA

akeehn@hrsa.gov

Phone: (301) 945-4817

Track Your Application

Use our track application tool